STEMCELL Technologies and Immudex have launched a new protocol combining EasySep™ Release positive selection with Immudex’s Dextramer® reagents. This innovation allows researchers to isolate rare antigen-specific T cells, MAIT cells and iNKT cells with exceptional ease, speed and purity.

Announced on November 18, 2025, this method is a simpler, more efficient alternative to traditional, often costly and demanding fluorescence-activated cell sorting (FACS).

“This collaboration brings together two best-in-class technologies to streamline a complex and critical step in immunology research, allowing scientists to optimize their time while yielding consistent results,” said Dr. Sharon Louis, Senior Vice President, Research and Development, STEMCELL. “As Scientists Helping Scientists, we are proud to release this new protocol in partnership with Immudex to help researchers gain efficiencies without compromising quality so that they can make discoveries with greater acceleration and confidence.”

Read the press release >